Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Vision Technologies is a private U.S. ophthalmic medical device company focused on specialty contact lenses and related eye-care products and services. The company manufactures customized rigid gas permeable, scleral, orthokeratology, pediatric, prosthetic, and silicone hydrogel soft lenses, and also provides consultation, clinician training, and laboratory services. Its marketed brands include NaturaLens, VIP Cone, PediaSITE, Prime KONE, AVT Scleral Lens, and Naturalens CRL. In 2025, AVT was reported as one of the companies combined into Wave Eye Care, a specialty contact lens division formed alongside EyePrint Prosthetics and Wave Contact Lens System. The business appears centered on commercial specialty vision correction rather than drug development or therapeutic biotech R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Vision Technologies.